O Seu Saber Ocupa um Lugar! DSpace

Repositório Comum >
HB - Hospital de Braga >
HB - Gastrenterologia >
HB - GAS - Artigos >

Please use this identifier to cite or link to this item: http://comum.rcaap.pt/handle/123456789/2108

Título: Crohn's disease in a southern European country: Montreal classification and clinical activity
Autor: Magro, F
Portela, F
Lago, P
Ramos de Deus, J
Vieira, A
Peixe, P
Ministro, P
Cremers, I
Cotter, J
Cravo, M
Tavares, L
Reis, J
Gonçalves, R
Lopes, H
Caldeira, P
Carvalho, L
Azevedo, L
Costa-Pereira, A
Palavras-chave: Doença de Crohn
Issue Date: 2009
Editora: Wiley
Citação: Inflamm Bowel Dis. 2009;15(9):1343-50.
Resumo: BACKGROUND: Given the heterogeneous nature of Crohn's disease (CD), our aim was to apply the Montreal Classification to a large cohort of Portuguese patients with CD in order to identify potential predictive regarding the need for medical and/or surgical treatment. METHODS: A cross-sectional study was used based on data from an on-line registry of patients with CD. RESULTS: Of the 1692 patients with 5 or more years of disease, 747 (44%) were male and 945 (56%) female. On multivariate analysis the A2 group was an independent risk factor of the need for steroids (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.1-2.3) and the A1 and A2 groups for immunosuppressants (OR 2.2; CI 1.2-3.8; OR 1.4; CI 1.0-2.0, respectively). An L3+L3(4) and L(4) location were risk factors for immunosuppression (OR 1.9; CI 1.5-2.4), whereas an L1 location was significantly associated with the need for abdominal surgery (P < 0.001). After 20 years of disease, less than 10% of patients persisted without steroids, immunosuppression, or surgery. The Montreal Classification allowed us to identify different groups of disease severity: A1 were more immunosuppressed without surgery, most of A2 patients were submitted to surgery, and 52% of L1+L1(4) patients were operated without immunosuppressants. CONCLUSIONS: Stratifying patients according to the Montreal Classification may prove useful in identifying different phenotypes with different therapies and severity. Most of our patients have severe disease.
Arbitragem científica: yes
URI: http://comum.rcaap.pt/handle/123456789/2108
Appears in Collections:HB - GAS - Artigos

Files in This Item:

File Description SizeFormat
Crohn's disease in a southern European country.pdf116,67 kBAdobe PDFView/Open
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


Estamos no RCAAP Governo Português separator Ministério da Educação e Ciência   Fundação para a Ciência e a Tecnologia

Financiado por:

© 2009 - REPOSITÓRIO COMUM - Comentários - Statistics